Reported Consolidated quarterly numbers for Akums Drugs Pharmaceuticals are:Net Sales at Rs 1,055.55 crore in March 2025 up 11.79% from Rs. 944.21 crore in March 2024.
Story continues below Advertisement
Quarterly Net Profit at Rs. 147.62 crore in March 2025 up 457.25% from Rs. 41.32 crore in March 2024.
EBITDA stands at Rs. 111.46 crore in March 2025 up 742.48% from Rs. 13.23 crore in March 2024.
Akums Drugs P EPS has increased to Rs. 9.64 in March 2025 from Rs. 2.89 in March 2024.
Akums Drugs P shares closed at 581.90 on May 23, 2025 (NSE)
| Akums Drugs Pharmaceuticals | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Mar'25 | Dec'24 | Mar'24 | | Net Sales/Income from operations | 1,055.55 | 1,010.41 | 944.21 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 1,055.55 | 1,010.41 | 944.21 | | EXPENDITURE | | Consumption of Raw Materials | 623.85 | 564.60 | 513.30 | | Purchase of Traded Goods | 19.49 | 30.27 | 63.49 | | Increase/Decrease in Stocks | -4.25 | 7.52 | -7.47 | | Power & Fuel | -- | -- | -- | | Employees Cost | 183.90 | 175.60 | 163.95 | | Depreciation | 40.00 | 44.52 | 33.95 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 138.65 | 111.06 | 207.95 | | P/L Before Other Inc., Int., Excpt. Items & Tax | 53.92 | 76.85 | -30.96 | | Other Income | 17.55 | 14.56 | 10.24 | | P/L Before Int., Excpt. Items & Tax | 71.46 | 91.41 | -20.72 | | Interest | 4.54 | 5.13 | 12.38 | | P/L Before Exceptional Items & Tax | 66.92 | 86.27 | -33.10 | | Exceptional Items | 8.22 | 4.78 | 0.22 | | P/L Before Tax | 75.14 | 91.05 | -32.88 | | Tax | -74.47 | 24.74 | 6.59 | | P/L After Tax from Ordinary Activities | 149.61 | 66.31 | -39.47 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 149.61 | 66.31 | -39.47 | | Minority Interest | -1.99 | -1.13 | -1.85 | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | 147.62 | 65.18 | -41.32 | | Equity Share Capital | 30.62 | 30.62 | 28.61 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 9.64 | 4.26 | -2.89 | | Diluted EPS | 9.64 | 4.26 | -2.89 | | EPS After Extra Ordinary | | Basic EPS | 9.64 | 4.26 | -2.89 | | Diluted EPS | 9.64 | 4.26 | -2.89 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
